0000320335-24-000018.txt : 20240422 0000320335-24-000018.hdr.sgml : 20240422 20240422164808 ACCESSION NUMBER: 0000320335-24-000018 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240422 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240422 DATE AS OF CHANGE: 20240422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBE LIFE INC. CENTRAL INDEX KEY: 0000320335 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] ORGANIZATION NAME: 02 Finance IRS NUMBER: 630780404 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08052 FILM NUMBER: 24861752 BUSINESS ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 BUSINESS PHONE: 972-569-4000 MAIL ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP SAVINGS & INVESTMENT PLAN DATE OF NAME CHANGE: 19820825 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY NATIONAL INSURANCE HOLDING CO DATE OF NAME CHANGE: 19820701 8-K 1 gl-20240422.htm 8-K (Q1 2024 EARNINGS RELEASE) gl-20240422
0000320335false00003203352024-04-222024-04-220000320335us-gaap:CommonStockMember2024-04-222024-04-220000320335us-gaap:SubordinatedDebtMember2024-04-222024-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2024
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 001-0805263-0780404
(State or other jurisdiction
of incorporation)
 
(Commission
File No.)
(I.R.S. Employer
ID No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (972569-4000
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par value per shareGLNew York Stock Exchange
4.250% Junior Subordinated DebenturesGL PRDNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02    Results of Operations and Financial Condition.
On April 22, 2024, Globe Life Inc. issued a press release announcing its first quarter 2024 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference in such filing.
Item 9.01    Financial Statement and Exhibits.
(a)Financial Statements of businesses or funds acquired.
Not applicable.
(b)Pro forma financial information.
Not applicable.
(c)Shell company transactions.
Not applicable
(d)Exhibits.
(104) Cover Page Interactive Data File (embedded within the Inline XBRL document)






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: April 22, 2024
 GLOBE LIFE INC.
 /s/ Christopher T. Moore
 Christopher T. Moore

Corporate Senior Vice President,
Associate Counsel and Corporate Secretary


EX-99.1 2 q1fy2024earningsrelease.htm EX-99.1 Document

globelifeheader.gif

GLOBE LIFE INC. REPORTS
First Quarter 2024 Results


McKinney, TX, April 22, 2024—Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2024, net income was $2.67 per diluted common share, compared with $2.28 per diluted common share for the year-ago quarter. Net operating income for the quarter was $2.78 per diluted common share, compared with $2.53 per diluted common share for the year-ago quarter.

HIGHLIGHTS:
l
Net income as an ROE was 21.3% for the three months ended March 31, 2024. Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.3% for the same period.
l
Net income increased 14% and net operating income increased 6% over the year-ago quarter.
l
At the American Income Life Division, life net sales and premiums increased over the year-ago quarter by 17% and 7%, respectively. Additionally, the average producing agent count increased 15% over the year-ago quarter.
l
At the Liberty National Division, the average producing agent count increased 14% over the year-ago quarter and life premiums increased 7%.
l
At the Family Heritage Division, health net sales increased 11% and premiums increased 8% over the year-ago quarter.
l
Total underwriting margin increased 5% over the year-ago quarter.
l
Net investment income grew 10% over the year-ago quarter.

















Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
1
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

RESULTS OF OPERATIONS

Net operating income, a non-GAAP(1) financial measure, has been used consistently by Globe Life’s management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

The following table represents Globe Life's operating summary for the three months ended March 31, 2024 and 2023:
Operating Summary
Per Share
Three Months Ended
March 31,
Three Months Ended
March 31,
20242023%
Chg.
20242023%
Chg.
Insurance underwriting income(2)
$3.41 $3.18 7$324,361 $311,037 4
Excess investment income(2)
0.46 0.30 5343,785 29,255 50
Interest on debt(0.30)(0.25)20(28,621)(24,867)15
Parent company expense
(0.03)(0.03)(2,826)(2,585)
Income tax expense(0.70)(0.61)15(66,227)(59,849)11
Stock compensation benefit (expense), net of tax(0.07)(0.05)(6,373)(4,949)
Net operating income 2.78 2.53 10264,099 248,042 6
Reconciling items, net of tax:
Realized gain (loss)—investments(0.10)(0.25)(9,321)(24,432)
Non-operating expenses(0.01)— (561)— 
Net income(3)
$2.67 $2.28 $254,217 $223,610 
Weighted average diluted shares outstanding 95,115 97,911 
(1)GAAP is defined as accounting principles generally accepted in the United States of America.
(2)Definitions included within this document.
(3)A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report.


Note: Tables in this earnings release may not sum due to rounding.

2
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
MANAGEMENT VS. GAAP MEASURES

Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates. Shareholders' equity and book value per share are the most directly comparable GAAP measures.
Three Months Ended
March 31,
20242023
Net income
$254,217 $223,610 
Net operating income
264,099 248,042 
Net income as an ROE(1)
21.3 %22.9 %
Net operating income as an ROE (excluding AOCI)(1)
14.3 %14.6 %
March 31,
20242023
Shareholders' equity$5,039,161 $3,846,291 
Impact of adjustment to exclude AOCI2,467,236 2,961,093 
Shareholders' equity, excluding AOCI$7,506,397 $6,807,384 
Book value per share$53.03 $39.74 
Impact of adjustment to exclude AOCI25.97 30.60 
Book value per share, excluding AOCI$79.00 $70.34 
(1) Calculated using average shareholders' equity for the measurement period.

INSURANCE OPERATIONS:

Life insurance accounted for 76% of the Company’s insurance underwriting margin for the quarter and 70% of total premium revenue.

Health insurance accounted for 23% of the Company's insurance underwriting margin for the quarter and 30% of total premium revenue.

Net sales of life insurance increased 7% for the quarter, and net health sales increased 9%.

The following table summarizes Globe Life's premium revenue by product type for the three months ended March 31, 2024 and 2023:
Insurance Premium Revenue
Quarter Ended
March 31, 2024March 31, 2023%
Chg.
Life insurance$804,265 $772,597 4
Health insurance341,019 322,493 6
Annuity— — 
Total$1,145,284 $1,095,090 5

3
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
INSURANCE UNDERWRITING INCOME

Insurance underwriting margin is management’s measure of profitability of the Company's life, health, and annuity segments’ underwriting performance, and consists of premiums less policy obligations (excluding interest on policy liabilities), commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life, health, and annuity segments, plus other income, less administrative expenses. It excludes the investment segment, interest on debt, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.

The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended March 31, 2024 and 2023:
Insurance Underwriting Income
Quarter Ended
March 31, 2024% of
Premium
March 31, 2023% of
Premium
%
Chg.
Insurance underwriting margins:
Life$309,011 38$291,274 386
Health93,770 2791,332 283
Annuity1,915 2,288 
404,696 384,894 5
Other income76 50 
Administrative expenses(80,411)(73,907)9
Insurance underwriting income$324,361 $311,037 4
Per share$3.41 $3.18 7

The ratio of administrative expenses to premium was 7.0%, compared with 6.7% for the year-ago quarter.

4
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (Direct to Consumer).

Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at https://investors.globelifeinsurance.com at "Financial Reports and Other Financial Information."
Life Underwriting Margin
Quarter Ended
March 31,
20242023
Amount% of PremiumAmount% of Premium% Chg.
American Income $187,068 45 $175,567 45 7
Direct to Consumer 58,585 24 56,161 23 4
Liberty National 30,713 34 27,690 32 11
Other 32,645 64 31,856 61 2
Total$309,011 38 $291,274 38 6
Life Premium
Quarter Ended
March 31,
20242023%
Chg.
American Income $414,044 $387,512 7
Direct to Consumer 248,040 247,667 
Liberty National 90,777 85,203 7
Other 51,404 52,215 (2)
Total$804,265 $772,597 4
Life Net Sales(1)
Quarter Ended
March 31,
20242023%
Chg.
American Income $97,195 $83,329 17
Direct to Consumer 28,563 32,467 (12)
Liberty National 21,605 21,979 (2)
Other 2,134 2,594 (18)
Total$149,497 $140,369 7
(1)Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.

5
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL
Health Underwriting Margin
Quarter Ended
March 31,
20242023
Amount% of PremiumAmount% of Premium% Chg.
United American $11,906 $12,938 10 (8)
Family Heritage 35,838 35 31,749 33 13
Liberty National 26,672 56 26,870 57 (1)
American Income 19,192 63 18,386 62 4
Direct to Consumer162 1,389 (88)
Total$93,770 27 $91,332 28 3
Health Premium
Quarter Ended
March 31,
20242023%
Chg.
United American $141,635 $132,607 7
Family Heritage 103,391 96,072 8
Liberty National 47,630 46,972 1
American Income 30,497 29,594 3
Direct to Consumer 17,866 17,248 4
Total$341,019 $322,493 6
Health Net Sales(1)
Quarter Ended
March 31,
20242023%
Chg.
United American $16,423 $15,380 7
Family Heritage 24,966 22,543 11
Liberty National 7,613 7,096 7
American Income 4,594 4,504 2
Direct to Consumer 804 550 46
Total$54,400 $50,073 9
(1)Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.

6
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL

Quarterly Average
Producing Agent Count(1)
Quarter EndedQuarter Ended
March 31,December 31,
20242023% Chg.2023
American Income11,139 9,714 15 11,131 
Liberty National 3,419 3,011 14 3,387 
Family Heritage 1,295 1,298 — 1,368 

(1) The quarterly average producing agent count is based on the actual count at the beginning and end of each week during the period.


INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less the required interest attributable to policy liabilities. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.
Excess Investment Income
Quarter Ended
March 31,
20242023%
Chg.
Net investment income$282,578 $257,105 10
Interest on policy liabilities(1)
(238,793)(227,850)5
Excess investment income$43,785 $29,255 50
Per share$0.46 $0.30 53
(1)Interest on policy liabilities is a component of total policyholder benefits, a GAAP measure.

Net investment income increased 10% and average invested assets increased 5%. Required interest on policy liabilities and average policy liabilities both increased 5%.

7
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
The composition of the investment portfolio at book value at March 31, 2024 is as follows:
Investment Portfolio
As of
March 31, 2024
Amount% of Total
Fixed maturities at fair value(1)
$18,144,353 90 
Mortgage Loans329,033 
Policy loans664,641 
Other long-term investments(2)
899,085 
Short-term investments58,413 — 
Total$20,095,525 
(1) As of March 31, 2024, fixed maturities at amortized cost were $19.5 billion, net of $7.0 million of allowance for credit losses.
(2) Includes $845 million of investments accounted for under the fair value option which have a cost of $829 million as of March 31, 2024.

Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of March 31, 2024 are as follows:
Fixed Maturity Portfolio by Sector
As of
March 31, 2024
Investment GradeBelow Investment GradeTotal Amortized Cost, net
Corporate bonds$15,138,591 $493,713 $15,632,304 
Municipals3,301,276 — 3,301,276 
Government, agencies, and GSEs(1)
441,417 — 441,417 
Collateralized debt obligations— 36,730 36,730 
Other asset-backed securities74,451 11,579 86,030 
Total$18,955,735 $542,022 $19,497,757 
(1) Government-Sponsored Enterprises

Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at March 31, 2024 and the corresponding amounts of net unrealized gains and losses recognized in accumulated other comprehensive income (loss).
As of
Amortized
Cost
Allowance for Credit LossesNet Unrealized Gains (Losses)Fair
 Value
March 31, 2024
$19,504,784 $(7,027)$(1,353,404)$18,144,353 

At amortized cost, net of allowance for credit losses, 97% of fixed maturities (97% at fair value) were rated “investment grade.” The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.24% during the first quarter of 2024, compared with 5.18% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending.


8
GL Q1 2024 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2024
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
Comparable information for acquisitions of fixed maturity investments is as follows:
Fixed Maturity Acquisitions
Quarter Ended
March 31,
20242023
Amount$682,427 $310,504 
Average annual effective yield5.9 %5.8 %
Average ratingA-A
Average life (in years) to:
Next call30.4 19.7 
Maturity32.3 24.9 

SHARE REPURCHASE:

During most of the first quarter, the Company was in a blackout period due to a potential acquisition that is no longer being actively considered. As a result, first quarter repurchases of Globe Life Inc. common stock were limited to 127,748 shares at a total cost of $15.6 million and an average share price of $122.13. Globe Life will immediately resume buybacks once the blackout for first quarter earnings is over. Our earnings guidance anticipates approximately $350 million to $370 million of share repurchases for the full year.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by volatile equity markets. Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.

EARNINGS GUIDANCE FOR THE YEAR ENDING DECEMBER 31, 2024:

Globe Life projects net operating income between $11.50 to $12.00 per diluted common share for the year ending December 31, 2024.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at https://investors.globelifeinsurance.com on the Investors page under “Financial Reports and Other Financial Information."


9
GL Q1 2024 Earnings Release


CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1) Economic and other conditions, including the continued impact of inflation, geopolitical events, and the recent pandemic on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;
2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);
3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;
4) Interest rate changes that affect product sales, financing costs, and/or investment portfolio yield;
5) General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may compromise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;
6) Changes in the competitiveness of the Company's products and pricing;
7) Litigation results;
8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);
9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;
10) The customer response to new products and marketing initiatives;
11) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;
12) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;
13) The impact of any reputational damage on the Company’s ability to attract and retain agents;

14) The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and
15) Globe Life’s ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.
Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

10
GL Q1 2024 Earnings Release


EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its first quarter 2024 earnings release conference call with financial analysts at 11:00 am (Eastern) tomorrow, April 23, 2024. Access to the live webcast and replay will be available at https://investors.globelifeinsurance.com on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at “Financial Reports.”
For additional information contact:
Mike Majors, Executive Vice President - Policy Acquisition and Chief Strategy Officer
Globe Life Inc.
3700 South Stonebridge Drive
P. O. Box 8080
McKinney, Texas 75070-8080
Phone: 972-569-3627 or email: investors@globe.life
Website: https://investors.globelifeinsurance.com

11
GL Q1 2024 Earnings Release


APPENDIX

GLOBE LIFE INC.
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
March 31,
 2024
2023
Revenue:
Life premium$804,265 $772,597 
Health premium341,019 322,493 
Other premium— — 
Total premium1,145,284 1,095,090 
Net investment income282,578 257,105 
Realized gains (losses)(11,799)(30,927)
Other income76 50 
Total revenue1,416,139 1,321,318 
Benefits and expenses:
Life policyholder benefits(1)
519,871 507,977 
Health policyholder benefits(2)
202,327 190,962 
Other policyholder benefits9,595 8,988 
Total policyholder benefits731,793 707,927 
Amortization of deferred acquisition costs99,478 92,322 
Commissions, premium taxes, and non-deferred acquisition costs148,110 137,797 
Other operating expense93,214 84,171 
Interest expense28,621 24,867 
Total benefits and expenses1,101,216 1,047,084 
Income before income taxes314,923 274,234 
Income tax benefit (expense)(60,706)(50,624)
Net income$254,217 $223,610 
Basic net income per common share$2.71 $2.32 
Diluted net income per common share$2.67 $2.28 
(1)Net of a remeasurement gain of $4.9 million for the three months ended March 31, 2024, and a remeasurement gain of $2.7 million for the same period in 2023.
(2)Net of a remeasurement gain of $3.2 million for the three months ended March 31, 2024, and a remeasurement loss of $2.0 million for the same period in 2023.
12
GL Q1 2024 Earnings Release
EX-101.SCH 3 gl-20240422.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gl-20240422_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 gl-20240422_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Domain] Class of Stock [Domain] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Class of Stock [Axis] Class of Stock [Axis] Security Exchange Name Security Exchange Name Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Cover page. Cover [Abstract] City Area Code City Area Code Common Stock, $1.00 par value per share Common Stock [Member] Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer 4.250% Junior Subordinated Debentures Subordinated Debt [Member] Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Entity Listings [Table] Entity Listings [Table] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Document Period End Date Document Period End Date Entity Listings [Line Items] Entity Listings [Line Items] Document Type Document Type EX-101.PRE 6 gl-20240422_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 globelifeheader.gif begin 644 globelifeheader.gif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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover page
Apr. 22, 2024
Entity Listings [Line Items]  
Document Type 8-K
Document Period End Date Apr. 22, 2024
Entity Registrant Name GLOBE LIFE INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-08052
Entity Tax Identification Number 63-0780404
Entity Address, Address Line One 3700 South Stonebridge Drive
Entity Address, City or Town McKinney
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75070
City Area Code 972
Local Phone Number 569-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000320335
Amendment Flag false
Common Stock, $1.00 par value per share  
Entity Listings [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value per share
Trading Symbol GL
Security Exchange Name NYSE
4.250% Junior Subordinated Debentures  
Entity Listings [Line Items]  
Title of 12(b) Security 4.250% Junior Subordinated Debentures
Trading Symbol GL PRD
Security Exchange Name NYSE
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 3 22 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover page Sheet http://www.globelifeinsurance.com/role/Coverpage Cover page Cover 1 false false All Reports Book All Reports gl-20240422.htm gl-20240422.xsd gl-20240422_def.xml gl-20240422_lab.xml gl-20240422_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "gl-20240422.htm": { "nsprefix": "gl", "nsuri": "http://www.globelifeinsurance.com/20240422", "dts": { "inline": { "local": [ "gl-20240422.htm" ] }, "schema": { "local": [ "gl-20240422.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "gl-20240422_def.xml" ] }, "labelLink": { "local": [ "gl-20240422_lab.xml" ] }, "presentationLink": { "local": [ "gl-20240422_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 27 }, "report": { "R1": { "role": "http://www.globelifeinsurance.com/role/Coverpage", "longName": "0000001 - Document - Cover page", "shortName": "Cover page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "gl-20240422.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "gl-20240422.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, $1.00 par value per share", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsLineItems", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Listings [Line Items]", "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsTable", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Listings [Table]", "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_SubordinatedDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubordinatedDebtMember", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "4.250% Junior Subordinated Debentures", "label": "Subordinated Debt [Member]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0000320335-24-000018-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000320335-24-000018-xbrl.zip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

=NR8XDBK MIT>)/ UH1-FKIA/<."5B)VR\Q!O2N5GT4]^?>Y*,;-!O/AT[&,,DDBAT4R<) MHS',H@^_'@%E0Y<,8/WTQPAFYJ%<\-R^8=(\2&_Y( MV#H#%W0'AL1UX50B("C^>S(/T-JG9 ?V<'F!M%>:(OI*IY)KE,IM^^:FMJ=J[/U6R *H^U:0W;)9'5Z(/F*P&F\00 M'*PDV]K"% 9TX^D6%@]LV)_@5[AI9#^Y=F*?'9N*.3V.KX&=NH@27D[#>;X) MB[[.13RJ9GVYN_WP]?+JYA/I_N_E]=?[JW]TR<6G[LT#N;S]"G_>=>^_7C_< MD_?_)!^N[A_NKMY_?;BZO2&7?USK;)#Z: MNJQ8VB%R"5NJ?I!4KCG33O0C"#%?4#Q9OR=W MS6'3U,.!1LJ2X9NE>OIC<@%374 ;'\FAR#?/+^SL#)0F%X]X-KY$7ZGJZBP!]8B'ZW+ MIR]-?E(4LA"%+$0AB]R%+,A*%0NA-_D$H7RF3SQYU*VDNG#ZI<2B7:#TNX'B M2@(#4U5)U8O6XZUJW8BF,+4C6>J6Z1."IR7EJ5KS;KC-8RA:WJ+])T_+U/+Y M*>+)$_M]54DHWT]MC8KE+>N2L6VOA3*"]&O%&445O8?+R)G"CK-@RW$41F^7 MKB=C^?9O\:2(@QVO\&+%:A>HDM;9\A1=T8-RE3A3HSZ&->),EL%-"WJB2 MWBJ=UI1O#Q=/'L G6M.EC$O@7-V/2=B;B>1\_RSW/__LIK*1U#Z[N.WE--0^GKMMJFNMI66[V614W+ M_)=FOEHSW[)EO5W=_*-[__"Y>_-P?\ ,MHP->UI9OG3.N7SZ-*8QRZ>,,R'T1"+$$QR[>?&B.DC_BV3 M*R;Z+NW#1%AA TS=7WV9CW-@^?KT/RDF_F-Y !K!4Z <2>3U4I[D![,8A;[G MC(GOV3W/]Q*/QC+Y"Z;KQR'Y[M&GS2O"3%'7P]1Z-&/#(:ABED:*Q0V(-QR% M46*C/H+J 7'ZJ;]V^;F6+I'8PP<\T&W[&U90"&",20D#%F F88K9V*'S#98] M2B-G@ 49P'X\1O;P&>7>*$'/"]ZBCK766H2CBB+:SW[H^^$3LVL\BS,=PCQA MD)A\\L,>)==>G_ZZAIO21CY+W'P6E8)<2>,S,E4EZ;1ER=IANFU6)X\3)FNT M\G6P//UD,>DT'V%?ZK:Y6(RHDEC#+M?BJYD6KX%D';2+I6K6!KBY.BT/FY6-.T=JZF:4>.5W^9U%(_9+.?%[KBU,)@'8 L M)31I"*LX?'.HE[LHU:5MFM",^FB&?H1^@N76C+I%&'018LB'\E\"G**D(MJT M,L#^4O2&>SY@S_JQ(7QU!-P(6#^X!+O=9H\.0A]L!.G1@/:]));@V4\7%U\F M:.8UV.(*(-?7@BGPKXBRS I5>;V.V'X MC6"B'<6?IDA])L[,Z8VSE+'XEY_,]KO-6^ZZ51\]9\M2K&URMBSXT-C\\0XM MXO1VYR!I4-ME@KTP65-O[Y '-8U%P"U)>)NAPO!ZH^_:HN8C! >TW[ MZ:P\6N+E+]I3D?ZT7D:&\[WT1$;/BP1[C9OZ X:?3I?2,PUA'246_-'[05TR MM),TRJ(3">G;7L0]EQJ@:07\I&[P$[4MJ88AZ:;>$ A*4TK$=XI>-.Z%H<^J M\/$3+8Y&[<_@?3]B#/HZA$$:41]:*?C2CT3MK]D-TM; M*W?%JD.V6H;4,K9L,%+17;\JO-G243N)/YW!X'LX% MHJN4!:DU* NRW0$'I'"^AW! CL&;$_;!J*<#"(;67/R^NY[S;S1RIAYLQH^SX\5;T@4MO"B2ZA)FB(I'5,RM2W=F=)$80^ M_5\8HY[(G7T2#O#*L!^ZH*F_-PVS*D$ -WGG&9B.ZR] J@0D@1D [^B#V;W=22 M<,1 :4\##Q1R8'^G+*NB/)(4L]2.X^M56^M,J%H>8A![GR&:G.]<,=>KVE3) MXOOK( R+>P[?8-"6;38M$NF->5X'<7SX&_&9*Q0C68^%?,#-$E3;!U]-5C@> MO2ATTX0=VCI !7M5;JF'@&[J[0/T!JC:9+5\#-NEWGX5<%S<)'SF)F$\ YJB MCM]3)PFCO4!.]U-SOPH$W3_:M**%]D\"-ZV"A,SANC]%MKM2=V6_>E43HKVG MX$800;HM2,?"C.1BZN==3OR\!A3COPRC41AA Z]>&+@K=RH"\EH[R*LIJ7I; M,CM;XEM*$VP5M0(;)KE&1Y>L;2]#A=@*L3V9P6WIFJ0K16$AQY+7!,EZ2UH@[VT%%!&\:HCDUS@G]%,(D M[Z&3N_.QY> MCV ]D4_WW2IABW?JL%(Q9)MAJ)*A6@)U6$+>G!QU*'A37KVIIR=_B3?9"8W@ MY1B==6DO(6$/9F*C(6^$>R\EX9\61!AF\ZQR6 M38ZIDR&FFI"48QF288KTX#*R1E4ET^H(UI20->V6I!0VQN5SCD6Z5)4OE.J0 M+J6VI8YI@F=3\W0I(;EUDUS3T"1%V[(^CQ!;(;8G,K@=R>A8DF46#>T=2W)S MYX6NYK.U\V2SM8^?$SJ[.#J_'X5!'&(WE"[B14>1%\^=,PMEP19<;9'L)7WM MT$?-7N(08,PK6LV=_6Y[/DL7PFREV(9_8([24FK3LSE->&DWER2X6H@>'TA8 M8?LHHC$P#0D_;2\0]EGF5!I$- OD/MI>P%O8\%>0B#KA8\ ^\P),5$R'*49^ M71*RD -6S(_H@ :Q]YU.6AV]P2^?Y6I%4<',*;TE6RUS__D]EJQ:VZ4-/?]9 M6SM(T7NCTQ*3/4P[ 25?2X6R3HB&Z.3N592(%]AS[.?WX>.1[+) M[H!OQYR( M3+D3)2@<20BX7]\)+OA]=LLVH<+;#1X-?9YOV);=YO.#'.&D>- MC^ (H5KP \$_Y@O<'_/F9[KPXZ*Z-J0P[J=8?OW.P,567,X#L*D8DM7>-X2] M3'L'JQ7SA%"X!L# MLZ7N[7ZQ7?&ICL5ZCZW$@-_@!PL]N]7"V/! MJ\_MQW#RI?TW'#^Q%'SRPQXEUUZ?8JO7( 2A($ ,('\2 K7'$_:[M&^G/DSJ MR1[QL+H;4OX%?)PE0R88-I]#ZQ%@#*I>P?#Y#C03O=W7\;@M>KO/B@N*WNZB MM_O&68K>[KG>*'J[EZFLZ"5S7Y@_Y 7@L0U9YA+SW6P''"2^:\4K7MMXH7)O MD4;OU;[UMC39T@_0ZOU0)3C- TU6RS>A!K1Z7ZK">3&G-:+C>W%R_ID=L+K@ M[[JB\[LDFKZOI<]*@=)#:%6MR*4WH&3D!7,J1:7(NA+\[WL;ZM6AU6AT:[R7REMG ? M+YK?> &[6(_/2!*R4/-!S?_)>VKN;L%*7!;B!F9#X.TKI2%R;;\5JS*B*_*6 MKG^)#J5U9(S:D:M?&;'$6CZY&VG"84O7Y*(@1%%P[QB,T8R#'8.WQH ^BSOS MW+^_\EI*Q]#ZKJ/W5--0^KJMMJFNMM56KV51TS+_I;5?K0QX'+C+_1\7=UUR MU_WR]>[RCXO[[J(O5J37ZHDA$!\XQG,8\N:]*UA/B?V* 26",7FR&6;%)CT? M!"9,$X2H>*%+W)0RV",9A0D-$IC6/(("QK 3CI(D?A@\THCT*"M"P*)1_AB4 M+H@]ET;4E;'MN$TB&J=^(BT!3R,Z2B-G8&-5 ICM' 3S*G!DA*,.X6UQ$CK? M.(36]X:(3,&YJ9HE64:; VIX!UGX-788<[+%_ZR: MGAU[#GP$*N\P-6=G5-2;.!V-?(KP*%"O ;7]9 !V(TXC)KJCT/>PX4#6R?R1 M!I1UNHN3*$2C@ -P3)1CQP/21UR5C#CW>/XWK* *HJ@]L$T.*GEO3+Z'B$G. M\.W)F,"DO]$$OGWMP2]<_!4H/LKZ%_@Z4'=BV4#;XK3?QWG!;T%KAI2"A8#- M#U>&1L(>>;B:@%(WGIC*V9H8$C[PGNM?7U RCHK>O+B[N;KY=$\^@;Q?W%QV MRUK\SVWR>*T8-(1KH0DL"'%F)45.&/< M$L&^???8Q'I1:,-$T6>/1_PB>-Y_A:FZM.\%,]#SZOR&]AADO]^'4?I1.)PK M ,8VOU_G1Y#)YQ"AZS2Q84=VP<\-@'!X-)@#6TL9M7%^W\'#"-.8K95Y \Z+(L6/PRYU0NXVO67RP!L4#9)DQ$'A MS(=D?TPE1WY$XJ/7-'4D9*#E"4Q[R)/VKB8S(YA"P^5ZDH#X<=GWUV-6.M_,M/NK%Z*-[)'1)I:NO8UQ%I:@U.4]NH&2\DX'3V):0Y78C+ MBZ\/5[*.'2C@D/$7_//\^O;V?_#G^X>+A^[G[LW#)N^B)![$ [H/ M(]@/I_X#VQCAL Q;'K(C]]P/PV^XKX%GD/"]B^5)9PG2L*<%F;O 8B_4 MQ59*"TG ]NS<"[OX9,^>'R^B?1]^.^=PL,0[ZQT/\]S#V+B M9#RF-NPY">7!M'Z:I!CAHA&SX+@7D;\&E-EW<$"85^(D""/CL;EXX@A@V EI MZH^Y3_#,\IG[0$?@&^..$Z1#&N&&#]^ -5)VY,=-)0WF?T._L^_"'%SXIQ^. M,C> 1P]P2'!@ CL[IV,>M0/'.(DPP\]C?XMG=3#3(#31.(L\P,0E'-T&=\IS MV"NSKTR" TAYKX_Q;7\LD_L47KM^4B "J>].',A%:@=P$HAC'D29A24/$TU: M4?139]JI9Z0+ZA$./8=Q>.(W!CR^$L^[@;Q6;0"G\!0KSK+H#@HH>(U^YC,^ MTA"#2.S*(6.%-*US&U'YE0-@G@-V@M?UD(TL95!(]S MX-H_4A;C9DEWK 0#6"/8(T(('D" MKX-_]ECXB4\S33S?^R_/-H0'LPB9@Z("!/[N.7C4P)CYO*^]X*G;<9P.1XQV M($*=9T2H=+*@G<$F^8@5A,-HO*33,RF88X7M.)C9D-F2P 7CPC3O<5J+FADE M-B0[NKSAA17@YPB4+1F$P$DN1XSE]@_.T^D[,G7_F)G@S]3U'![M#Q\C>\A9 M\<14VV80VMDC]]-#V!GC0W78H)]AH>AO%$Z/L$^X\:1P1TP#+\32': /\X(Y MM9J,&OQ4">;:!^,?, >;TS&RIR'3*9'>Q&@R03?^X.-]AETRH0$SQK?1(^R# M_\TX-[,-?$=S^;N!V:/(^XY!XI$/:S[+E!TFXLRSA&26 /VX*?S-J2).S-^I5&&?&48^\2T],_2>(\WD%CPKL#B$K1A6X;GHR["NE1X84QK%F>LT%ZB8;5 ( MO9N8IH4='P4QNW5@MPN1%^,SS&*OW:86;!/HG$,CYC5F\_0FC.0>Y1 8.?30 M 82O3?:==1P[FWUK3ADF3B"_!\E*Q.,=X,S+?()?/ 7, YJ.@,;2B_#ZDY-F MZE3:/;Y,O""QO['[T !O(?U%@IAMPVB)9^^NF.*USLCE;%?B M;LIP1!,/K1]&]2:^?.8W_AI/U)"+"5X>@VQ43:NL,W ZDJRMZ\3YKQCKVK"& MJ5]FNW"H]D#7V+;%]YS)E2?/DF'7@(ZWS@M#_9MSON;M AX5(HK\1D*!B"R, MQ DWM0V3>"VO(!8O&@YV7IDZO@-8"&7:&4 ^\. MAPS_@OT[8G9 #>C3HGGA-I[?78*^CZD6J.$L,D)@2V(8&4ZN?Z?NX_RWEJ\V\(U9P&,R#]3?X03: M8[."ZY6C+YR^+F=>!3:;@96CRF @QIYX2-P'9RY+YF;;*:J(Q.+UBD)J(!SWL1S!$+!"&"Y\1,D!,-- O9,>\\Z'M(K GL1$ - )EG/K* ML[T5(VD819L#]$T"// <2&U@8UE%B0S XP5_.\!_4_"9!_])P5'%<*'-Q0_$ M, IALT6)#9ATSN&=LJI;<1@$U&?U+<'L.AS."/:4>?A8P9$.6=LEU!2, V5F MF$LM?%(AKN&9:1I86BN[3*,G[NZ$'"-[E*DS.T%E.*OETPV8B9295O8IZ5&& MJ4F#$9;&=#C&"VB8!AG>BU7>FIZ(.+9T"T#5<4AW1_$VG=_9VWXNBTC2RXOK:_)7]_WEQ?U#=4%CW*R6"/XXRSB8 MAN+!.<)P!CA,(7FB/F.#%' ,FO-.4@LD5-FQ9@2]Q?^TQ9 M>(:#ZZ1)(L+E3.WXH]GW_J(]XCGHTEW-I13Q,K/\FGP9A"(MYEW,5#?* 'NK MO.Y11%I,HBL+ZK\>$@ACIY,P]WSJ$^V!'\5D9Q-<<-JP8"T ^K@U<#N&;.FM M;4K@@F*UM>T:OSY?<;9E;OO-9^KUJK*JY6LGFR5B+WG5*G=JRU(3XB1U)4I6 M)61#'5X\.,^2E>:#:PR5YB2EJA92B(C[\F5SYNM[WRCY;/\;+)X$)VPX<;-+ MHG]@WN<7L+8>'O?(.?F"]PP+%8^9C;\<>+1/[O%NB3Z.R2W> (''=9A(9KX5 M+67)GG(J.D@ON0]3<"SODS"@O,3],1D?LE#/_BSLF?(*[.(YS752WJ&?0]&"5*H)5U0E6N?FS M_=5ILO\)TQI.V_GFXLL7S(_^W\+=67+'NTZPJ&HT'6*Y@9>W-Q^Z-_?=#_BO M^]OKJP\7#_##+)>$W'XDMU^Z=Q>8?7*?\VINJ3O-='%'/J>V9&X09VU6P KOU'"DM/7EUU?\JHJNKXLK5+\1217ZMCPKO8?? M_+=HZK)T-CM\X>OCR\X=8J)2FC>,5QF5WJGCPS[*6^\R1O%)GJ#@Z?$WGJRN M$@-M5U56BS"D%CUFUJVKA*5,VXHA:2VS\F5FA7R54[XL2Y/,3M&2V/NNEGO< MPO?'IW*6"%SQ/6+Z9(WJP>N&*BEJT6K1HE;_47BC:9+1*5IBO=KE^H]/95[2 MK FFJ6)5[%EVBO:N\JZ?X$W)W29=*:EI>F#UZIM@FO;2YK4DNJ%*JF%*6KNL MO4]/X''5A*]*QX3_E)+RM1'>V@U-YNOA\++MM3:-%?,,M+8FF=:AFJ\*KVTG MWIB6I"HG#*8V(MAUE]4*(8^VAQ6#L(0&C<]J;:0J%EEYHZJ2U>FL\$0$O$[+ M%EV1.IIU$K:\8)K*K9IE?K(1;NEM5N1(>*/ELBA62SBB)62+6?0,75(?M.21 MPXB#R&IMD.H583+4EJ3J6U['BLAA:?FJ:_"?6C0JU[615<[.41Q#1N#%"Z+%CH4U;;6)>=D UQCL]CBA7Z9<<' M0;,J$8/0=UG/\S_->6VF6,V:Y+-J&=KK:' GF.**FURM"2:W8O<0FJ+!B:VH M6HL[HJ. MKDN:6C1/5[A;1PF@&9)ZREOO1KA;5UC&D\9)(VQ3Q39I MK2VUM*(*(/RGH[#&D-JMFKA/)8_N]]:!/6MMIC)>U2(.K$JJHH*+M6465FGB M^WOTOVK"5\6P)*5PB9MC\74O"0W%P=+E-CH"7'[RA(9-7CBF#4^:L_(D8A[T M;,)&5Q6;IZN&U-&*WE2+8,%1''++D#3]A(&<&B1;/6N;P!I-7''R)G/#146; M$FG FY8B64I+5+0I&5M,16II1ADKVA2RA[I5QDQ07@RPRC57MCXIU;9A1,X5 MEU#7-1.<$'7+9+!\RSZQZRBDM4;2JNE2JS ^XRC2*J(WVSE6WMNQYY!@ZL.0$8U@><-A&)!X8$>U=6KJNAF4WN3+ M-2@C((2KK,*EGQX<+5P&X3+4V67XX/EI0MTF.@V9#'"U?TX,ZF;XBRV\E#M# M8:S4-DLON5\BY+>Z\JMMF9%W%/EE.]W?$AO&_3VK(317I6EH1X]>,)E""Q:< M_08W4_QQL8R3+B]A ?^=QHG7'_-?>8%+@^3M.7]L/SQHO\0#C3=LF%ZA'.F= MBX3198OYDGCC$/:)32(ZI':ST@;__V9 [!-[O8TI:/XQ(,J#P7T0I M@0TZ&<2$ @E=\MF.G '158EHBF;PU+:-8\*Q;67,V.9;OQ>ZX C@*+I,%@M) MK0I!YC]5A>5:-5BNR]J^6(Z=8C*6*SNR/%N6@;Q=+4WVY+G)(#-O\]_*S(0R M^XK=BT/T.3=^94YP'(KI! MRHYG:T:K",:E1M8TD63:KQYS6IVORIWID<7[U M.]GC&_.M$V6;=.TH #6*R1WU0;KI(D<6_NR%[AC^&B1#__?_ U!+ 0(4 Q0 M ( .&EECOZFAPE1 %IX / " 0 !G;"TR,#(T M,#0R,BYH=&U02P$"% ,4 " #AI98N(PDW)8" 3"0 #P M @ '"$ 9VPM,C R-# T,C(N>'-D4$L! A0#% @ X:66.+9#JY> M" %3P !, ( !A1, &=L+3(P,C0P-#(R7V1E9BYX;6Q0 M2P$"% ,4 " #AI98)@QI\I<, "C:@ $P @ $4' M9VPM,C R-# T,C)?;&%B+GAM;%!+ 0(4 Q0 ( .&EEA"EMZM"@@ +8^ M 3 " =PH !G;"TR,#(T,#0R,E]P&UL4$L! A0# M% @ X:66'!P/,==1@ ?=H$ !L ( !%S$ '$Q9GDR L,#(T96%R;FEN9W-R96QE87-E+FAT;5!+!08 !@ & (8! "M=P ! end XML 19 gl-20240422_htm.xml IDEA: XBRL DOCUMENT 0000320335 2024-04-22 2024-04-22 0000320335 us-gaap:CommonStockMember 2024-04-22 2024-04-22 0000320335 us-gaap:SubordinatedDebtMember 2024-04-22 2024-04-22 0000320335 false 8-K 2024-04-22 GLOBE LIFE INC. DE 001-08052 63-0780404 3700 South Stonebridge Drive McKinney TX 75070 972 569-4000 false false false false Common Stock, $1.00 par value per share GL NYSE 4.250% Junior Subordinated Debentures GL PRD NYSE false 2024-04-22 2024-04-22